NCT04737616
Continuous Monitoring and Management of Vaginal Health Via Multifunctional OCT/OCTA/OCE Endoscopy
StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved at least 1 year 1 month later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Jul 2026 to Sep 2027
- Eligibility criteria expanded, about 5 words
- Minor Trial status: Recruiting to Active, Not Recruiting
- Site details revised
- Notable Primary and study completion dates: Jul 1, 2024 to Jul 2026
- Study site revised
- Collaborators expanded, about 5 words
- Notable Primary and study completion dates: Jul 1, 2023 to Jul 1, 2024v3
- Notable Primary and study completion dates: Jul 1, 2022 to Jul 1, 2023v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Vaginal epithelial thickness (VET)
Timeframe: 2 years
Secondary (3)
blood vessel density
Vaginal Health Index (VHI)
Lactobacillus abundance
Arms and interventions
CO2 Laser +OCTExperimental
Postmenopausal women with genitourinary syndrome of menopause who will receive CO2 vaginal laser treatment
OCT onlyExperimental
Premenopausal, peri-menopausal and postmenopausal women who will only get one time OCT scan
Devices: CO2 laser, OCT
Sites
1 site in 1 country
- Beckman Laser Institute and Medical ClinicIrvine, California, United States